We Health
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $14M
Investors
- 3
About We Health
Established in 2016 and based in Shanghai, We Health is a medical technology company that focuses on the research and development of genetic testing services. It acquired 19 patents and 26 CE certifications. The company was recognized as the National High-tech Enterprise. It has a testing laboratory and production base, with about 10,000 square meters. Its team members came from Fudan University, Harvard University, University of Southern California and other universities. The company's business is genetic testing services, including genetic disease testing, oncology genetic testing, and fertility testing. The genetic disease testing includes 15 categories, such as skin genetic disease testing, bone genetic disease, and blood system genetic disease testing. It has established detection platforms such as gene sequencing, structural variation detection, and QPCR.
Who invested in We Health
3 investors across 3 rounds
See all investors in We Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about We Health
Who invested in We Health?
We Health has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has We Health raised?
We Health has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did We Health last raise money?
We Health's most recent round on record is a Series B, in Dec 2023.
What does We Health do?
Established in 2016 and based in Shanghai, We Health is a medical technology company that focuses on the research and development of genetic testing services.
Where is We Health headquartered?
We Health is headquartered in Shanghai, China.
Which VCs invest in companies like We Health?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at We Health's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like We Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.